AtriCure, Inc.
ATRC
$28.29
-$0.50-1.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 552.16M | 534.53M | 518.31M | 499.95M | 480.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 552.16M | 534.53M | 518.31M | 499.95M | 480.08M |
| Cost of Revenue | 134.70M | 133.75M | 130.24M | 126.42M | 121.19M |
| Gross Profit | 417.46M | 400.78M | 388.06M | 373.52M | 358.88M |
| SG&A Expenses | 319.51M | 311.02M | 304.86M | 299.87M | 295.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 555.12M | 543.98M | 544.77M | 534.02M | 515.13M |
| Operating Income | -2.97M | -9.45M | -26.46M | -34.07M | -35.05M |
| Income Before Tax | -3.26M | -10.16M | -27.83M | -35.27M | -37.10M |
| Income Tax Expenses | 1.33M | 1.29M | 947.00K | 1.09M | 1.08M |
| Earnings from Continuing Operations | -4.59 | -11.45 | -28.77 | -36.36 | -38.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.59M | -11.45M | -28.77M | -36.36M | -38.18M |
| EBIT | -2.97M | -9.45M | -26.46M | -34.07M | -35.05M |
| EBITDA | 17.75M | 11.08M | -6.21M | -14.07M | -15.69M |
| EPS Basic | -0.10 | -0.24 | -0.61 | -0.77 | -0.81 |
| Normalized Basic EPS | -0.04 | -0.13 | -0.37 | -0.47 | -0.49 |
| EPS Diluted | -0.10 | -0.24 | -0.61 | -0.77 | -0.81 |
| Normalized Diluted EPS | -0.04 | -0.13 | -0.37 | -0.47 | -0.49 |
| Average Basic Shares Outstanding | 191.93M | 190.99M | 190.16M | 189.34M | 188.53M |
| Average Diluted Shares Outstanding | 193.56M | 191.91M | 190.16M | 189.34M | 188.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |